Evidence map›Paper›PMID 41635704›Full record

ReviewThe Lancet regional health. Southeast Asia2025

Influenza surveillance and vaccine policy in Thailand-a historical perspective.

Martha P Montgomery, Prabda Praphasiri, Darunee Ditsungnoen, Pasakorn Akarasewi, Malinee Chittaganpitch, Pilaipan Puthavathana, Khanchit Limpakarnjanarat, Ponthip Wirachwong, Tawee Chotpitayasunondh, Narumol Sawanpanyalert and 4 more

Abstract readReview
In one paragraph

Review in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Martha P MontgomeryThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Prabda PraphasiriThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Darunee DitsungnoenThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Pasakorn AkarasewiDepartment of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
Malinee ChittaganpitchNational Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Pilaipan PuthavathanaMahidol University, Bangkok, Thailand.
Khanchit LimpakarnjanaratDepartment of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
Ponthip WirachwongGovernment Pharmaceutical Organization, Bangkok, Thailand.
Tawee ChotpitayasunondhQueen Sirikit National Institute for Child Health, Bangkok, Thailand.
Narumol SawanpanyalertDepartment of Medical Services, Ministry of Public Health, Nonthaburi, Thailand.
Chaninan SonthichaiThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
William W DavisThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Sonja J OlsenU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Supamit ChunsuttiwatDepartment of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prior to 2000, influenza burden in Thailand and other low- and middle-income countries was underappreciated, and influenza vaccination was uncommon. For the last two decades, Thailand Ministry of Public Health (MOPH) and U.S. Centers for Disease Control and Prevention have collaborated to understand influenza burden and the costs and benefits of influenza vaccination in Thailand. Built on a long-standing national disease notification system, Thailand MOPH established robust surveillance platforms for pneumonia and influenza, which provided insights into seasonality, disease incidence, and populations at risk for severe disease. In 2004, human cases of avian influenza brought attention to influenza's pandemic potential. Concern for an influenza pandemic combined with evidence of the cost effectiveness of influenza vaccination accelerated vaccine policy. Surveillance and vaccination policy were leveraged for and strengthened by the 2009 influenza H1N1 and COVID-19 pandemics. This personal view documents Thailand's experience in developing influenza surveillance and influenza vaccination policy.

Indexed as

InfluenzaSurveillanceThailandVaccination

Identifiers

PMID41635704
PMCPMC12862145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.